SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-138206
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:39
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d801395ddefa14a.htm DEFA14A 40287
2 GRAPHIC g801395txs10g1.jpg GRAPHIC 165404
3 GRAPHIC g801395txs11g1.jpg GRAPHIC 74170
4 GRAPHIC g801395txs12g1.jpg GRAPHIC 77647
5 GRAPHIC g801395txs1g1.jpg GRAPHIC 59165
6 GRAPHIC g801395txs2g1.jpg GRAPHIC 209895
7 GRAPHIC g801395txs3g1.jpg GRAPHIC 138617
8 GRAPHIC g801395txs4g1.jpg GRAPHIC 134418
9 GRAPHIC g801395txs5g1.jpg GRAPHIC 149670
10 GRAPHIC g801395txs6g1.jpg GRAPHIC 142015
11 GRAPHIC g801395txs7g1.jpg GRAPHIC 165514
12 GRAPHIC g801395txs8g1.jpg GRAPHIC 130168
13 GRAPHIC g801395txs9g1.jpg GRAPHIC 136231
  Complete submission text file 0001193125-24-138206.txt   2222999
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39083 | Film No.: 24944228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)